Kelly J. Henning

Kelly J. Henning
NationalityAmerican

Kelly J. Henning is an epidemiologist and medical doctor currently leading the public health program of Bloomberg Philanthropies. She has led the program since it began in 2007. She was the first person to serve as director of epidemiology for the New York City Department of Health and Mental Hygiene.[1][2] Henning said of working in public health "I have the opportunity to help improve the health and lives of millions of people. That's what really speaks to me."[3]

Career

Henning received her MD from Tufts University School of Medicine and completed internal medicine training at the University of Pennsylvania where she also served as an associate professor of infectious diseases and hospital epidemiology.[2] She completed her epidemiology training at the U.S. Center for Disease Control and Prevention Epidemic Intelligence Service in 1988.[4]

Henning served as the first director of the epidemiology division of New York City's Department of Health and Mental Hygiene from 2003 to 2006.[2] Since 2007, she has led the public health program of Bloomberg Philanthropies, the foundation established by former New York City Mayor Mike Bloomberg. Priorities for the program include devoting $1 billion to curbing tobacco use in poorer countries, reducing the number of preventable traffic injuries and deaths around the world, and helping countries to improve public health data collection with the goal of addressing public health problems."[5][6][7][8]

Henning characterized the work on curbing tobacco use as focused on "demand reduction." She described this as "smoke-free public places, advertising bans, availability of cessation services, pack warnings, and other ways of educating the public, and perhaps most importantly raising taxes on tobacco because price is one of the key drivers to helping people quit and not start using tobacco."[9]

On the wider work with Bloomberg Philanthropies on noncommunicable diseases, Henning told NPR: "Cancer, heart attacks, stroke, chronic lung disease: this is a group of diseases that cause more than 40 million deaths a year."[10]

Henning has contributed to more than 30 peer-reviewed research publications and presented at more than 11 national scientific meetings. She has been invited to deliver more than 28 lectures or lead discussions on a range of topics including bioterrorism, pandemic flu and smallpox.[11][12]

Selected publications

  • Henning KJ, Pollack DM, Friedman SM. A neonatal hepatitis B surveillance and vaccination program: New York City, 1987 to 1988. Am J Public Health. 1992;82:885-888[13]
  • Frieden TR, Sowell AL, Henning KJ, Huff DL, Gunn. Vitamin A levels and severity of measles. New York City. Amer J Dis Child. 1992;146:182-186[14]
  • Henning KJ, Jean-Baptiste E, Singh T, Hill RH, Friedman SM. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan. J Rheumatol. 1993;20:273-278[15]
  • Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York. J Rheumatol. 1993;20:666-672[16]
  • Henning KJ, Bell E, Braun J, Blum S. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am J Med. 1995;99:132-136[17]
  • Henning KJ, DeLencastre H, Eagan J, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J. 1996;15:848-54[18]
  • Henning KJ, White M, Sepkowitz K, Armstrong DA. A national survey of immunization practices following allogeneic bone marrow transplantation. JAMA. 1997; 277:1148–1151.[19]
  • Henning KJ, Hall EL, Dwyer DM, Billman L, Schuchat A, Johnson JA, Harrison LH. Invasive Group B streptococcal disease in Maryland nursing home residents. J Infect Dis. 2001; 183:1138–1142.[20]
  • Henning KJ, Brennan PJ, Hoegg C, O'Rourke E, Dyer BD, Grace TL. Health system preparedness for bioterrorism: bringing the tabletop to the hospital. Infect Control Hosp Epidemiol. 2004;25:146-155[21]
  • Henning KJ, What is syndromic surveillance? Morbidity and Mortality Weekly Report (Supplement). 2004;53:7-11[22]
  • Frieden TR, Das-Douglas M, Kellerman SE, Henning KJ. Applying public health principles to the HIV epidemic. N Engl J Med. 2005; 353:2397–2401[23]
  • Myers JE, Henning KJ, Frieden TR, Larson K, Begier B, Sepkowitz KA. Written consent for human immunodeficiency virus testing. Public Health Rep. 2007;122:433-4.[24]
  • Larson K, Henning KJ, Peden M. Editorial: The importance of data for global road safety. Traffic Injury Prevention. 2012; 13 (S1):3-4.[25]
  • Larson K, Henning KJ. Implementing proven road safety interventions saves lives. Injury Int. J. Care Injured. 2013; 44 (S4):S3[26]

References

  1. ^ "Kelly Henning". Health Affairs. doi:10.1377/hauthor20150928.576239 (inactive 1 November 2024). Retrieved 10 May 2018.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
  2. ^ a b c "Dr. Kelly Henning | Bloomberg Philanthropies". Bloomberg Philanthropies. Retrieved 2018-05-10.
  3. ^ "Dr Kelly Henning, Bloomberg Philanthropies Public Health Lead talks tobacco control on the eve of WCTOH". 17th World Conference on Tobacco or Health. Retrieved 10 May 2018.
  4. ^ "Epidemic Intelligence Service Officers by Class Year, 1951–2005". American Journal of Epidemiology. 174 (suppl 11): i–x. 2011-11-30. doi:10.1093/aje/kwr449. ISSN 0002-9262.
  5. ^ "Billionaire Michael Bloomberg Wants to Make the World Quit Smoking". Fortune. Retrieved 2018-05-10.
  6. ^ "The High Toll of Traffic Injuries: Unacceptable and Preventable". World Bank. Retrieved 2018-05-10.
  7. ^ Guest, CIO Central. "Bloomberg's Data Initiative: Big Data For Social Good In 2018". Forbes. Retrieved 2018-05-10.
  8. ^ "For better health, countries must understand death". Devex. 2016-08-23. Retrieved 2018-05-10.
  9. ^ "STOP – Bloomberg's response to tobacco industry tactics". Devex. 2018-03-23. Retrieved 2018-05-14.
  10. ^ "Michael Bloomberg Aim To Fight Noncommunicable Diseases Complicated By President's Pitch". NPR.org. Retrieved 2018-05-14.
  11. ^ Henning, Kelly J.; Brennan, Patrick J.; Hoegg, Cindy; O'Rourke, Eileen (February 2004). "Health System Preparedness for Bioterrorism: Bringing the Tabletop to the Hospital". Infection Control and Hospital Epidemiology. 25 (2): 146–155. doi:10.1086/502366. ISSN 0899-823X. PMID 14994941. S2CID 35069977.
  12. ^ Henning, Kelly J. (2004-09-24). "What is syndromic surveillance?". MMWR Supplements. 53: 5–11. ISSN 2380-8942. PMID 15714620.
  13. ^ Henning, K J; Pollack, D M; Friedman, S M (June 1992). "A neonatal hepatitis B surveillance and vaccination program: New York City, 1987 to 1988". American Journal of Public Health. 82 (6): 885–888. doi:10.2105/ajph.82.6.885. ISSN 0090-0036. PMC 1694181. PMID 1585970.
  14. ^ Frieden, T. R.; Sowell, A. L.; Henning, K. J.; Huff, D. L.; Gunn, R. A. (February 1992). "Vitamin A levels and severity of measles. New York City". American Journal of Diseases of Children. 146 (2): 182–186. doi:10.1001/archpedi.1992.02160140048019. ISSN 0002-922X. PMID 1285727.
  15. ^ Henning, KJ; Jean-Baptiste, E; Singh, T; Hill, RH; Friedman, SM (February 1993). "Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan". The Journal of Rheumatology. 20 (2): 273–8. ISSN 0315-162X. PMID 8474064.
  16. ^ Back, E. E.; Henning, K. J.; Kallenbach, L. R.; Brix, K. A.; Gunn, R. A.; Melius, J. M. (April 1993). "Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York". The Journal of Rheumatology. 20 (4): 666–672. ISSN 0315-162X. PMID 8496862.
  17. ^ Henning, Kelly J.; Bell, Eleanor; Braun, James; Barker, Nancy D. (August 1995). "A community-wide outbreak of hepatitis a: Risk factors for infection among homosexual and bisexual men". The American Journal of Medicine. 99 (2): 132–136. doi:10.1016/S0002-9343(99)80132-6. ISSN 0002-9343. PMID 7625417.
  18. ^ Henning, Kelly J.; Delencastre, Herminia; Eagan, Janet; Boone, Natalie; Brown, Arthur; Chung, Marilyn; Wollner, Norma; Armstrong, Donald (October 1996). "Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection". The Pediatric Infectious Disease Journal. 15 (10): 848–54. doi:10.1097/00006454-199610000-00004. ISSN 0891-3668. PMID 8895914.
  19. ^ Henning, Kelly J. (1997-04-09). "A National Survey of Immunization Practices Following Allogeneic Bone Marrow Transplantation". JAMA: The Journal of the American Medical Association. 277 (14): 1148–51. doi:10.1001/jama.1997.03540380062032. ISSN 0098-7484. PMID 9087470.
  20. ^ Henning, Kelly J.; Hall, Elvira L.; Dwyer, Diane M.; Billmann, Lillian; Schuchat, Anne; Johnson, Judith A.; Harrison, Lee H. (April 2001). "Invasive Group B Streptococcal Disease in Maryland Nursing Home Residents". The Journal of Infectious Diseases. 183 (7): 1138–1142. doi:10.1086/319278. ISSN 0022-1899. PMID 11237844.
  21. ^ Henning, Kelly J.; Brennan, Patrick J.; Hoegg, Cindy; O'Rourke, Eileen; Dyer, Bernard D.; Grace, Thomas L. (February 2004). "Health System Preparedness for Bioterrorism: Bringing the Tabletop to the Hospital". Infection Control & Hospital Epidemiology. 25 (2): 146–155. doi:10.1086/502366. ISSN 0899-823X. PMID 14994941. S2CID 35069977.
  22. ^ Henning, Kelly J. (2004). "What is Syndromic Surveillance?". Morbidity and Mortality Weekly Report. 53: 7–11. JSTOR 23315680.
  23. ^ Frieden, Thomas R.; Das-Douglas, Moupali; Kellerman, Scott E.; Henning, Kelly J. (December 2005). "Applying Public Health Principles to the HIV Epidemic". New England Journal of Medicine. 353 (22): 2397–2402. doi:10.1056/nejmsb053133. ISSN 0028-4793. PMID 16319391.
  24. ^ Myers, Julie E.; Henning, Kelly J.; Frieden, Thomas R.; Larson, Kelly; Begier, Beth; Sepkowitz, Kent A. (2007). "Written Consent For Human Immunodeficiency Virus Testing". Public Health Reports. 122 (4): 433–434. ISSN 0033-3549. PMC 1888515. PMID 17639644.
  25. ^ Larson, Kelly; Henning, Kelly; Peden, Margie (12 March 2012). "The importance of data for global road safety". Traffic Injury Prevention. 13:sup1: 3–4. doi:10.1080/15389588.2012.671737. PMID 22414121. S2CID 37038339.
  26. ^ Larson, Kelly; Henning, Kelly (December 2013). "Implementing proven road safety interventions saves lives". Injury. 44: S3. doi:10.1016/s0020-1383(13)70205-5. ISSN 0020-1383. PMID 24377775.